Genetic contributors to frontotemporal lobar degeneration: Beyond monogenic disease

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 11, 2011, Pages 988-1001

  Borroni, B ^a   Pilotto, A ^a   Bianchi, M ^a   Gilberti, N ^a   Padovani, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Frontotemporal dementia; Frontotemporal lobar degeneration; Genetics; Polymorphism; Risk factors

Indexed keywords

APOLIPOPROTEIN E; PROGRANULIN; TAU PROTEIN;

ALZHEIMER DISEASE; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR CHANGE; CLINICAL FEATURE; FRONTOTEMPORAL DEMENTIA; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MOTOR NEURON DISEASE; NEUROIMAGING; PARKINSONISM; PATHOGENESIS; PHENOTYPE; PROGNOSIS; PROGRESSIVE NONFLUENT APHASIA; REVIEW; SEMANTIC DEMENTIA;

FRONTOTEMPORAL LOBAR DEGENERATION; GENETIC DISEASES, INBORN; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; TAU PROTEINS;

EID: 80052282557     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955711797068517     Document Type: Review

References (158)

1. Neary, D.; Snowden, J.S.; Gustafson, L.; Passant, U.; Stuss, D.; Black, S.; Freedman, M.; Kertesz, A.; Robert, P.H.; Albert, M.; Boone, K.; Miller, B.L.; Cummings, J.; Benson, D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 1998, 51, 1546-54.
2. McKhann, G.M.; Albert, M.S.; Grossman, M.; Miller, B.; Dickson, D.; Trojanowski, J.Q. Work Group on Frontotemporal Dementia and Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol., 2001, 58, 1803-9.
3. Mackenzie, I.R.; Neumann, M.; Bigio, E.H.; Cairns, N.J.; Alafuzoff, I.; Kril, J.; Kovacs, G.G.; Ghetti, B.; Halliday, G.; Holm, i.e.; Ince, P.G.; Kamphorst, W.; Revesz, T.; Rozemuller, A.J.; Kumar- Singh, S.; Akiyama, H.; Baborie, A.; Spina, S.; Dickson, D.W.; Trojanowski, J.Q.; Mann, D.M. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta. Neuropathol., 2010, 119, 1-4.
4. Goldman, J.S.; Farmer, J.M.; Wood, E.M.; Johnson, J.K.; Boxer, A.; Neuhaus, J.; Lomen-Hoerth, C.; Wilhelmsen, K.C.; Lee, V.M.; Grossman, M.; Miller, B.L. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology, 2005, 65, 1817-9.
5. Goldman, J.S.; Adamson, J.; Karydas, A.; Miller, B.L.; Hutton, M. New genes, new dilemmas: FTLD genetics and its implications for families. Am. J. Alzheimers. Dis. Other. Demen. 2007, 22, 507-15.
6. Van Swieten, J.C. Genetic basis of frontotemporal dementia. Lancet. Neurol., 2007, 10, 840-1.
7. Wilhelmsen, K.C.; Lynch, T.; Pavlou, E.; Higgins, M.; Nygaard, T.G. Localization of disinhibition-dementia-parkinsonismamyotrophy complex to 17q21-22. Am. J. Hum. Genet., 1994, 55, 1159-65.
8. Baker, M.; Kwok, J.B.; Kucera, S.; Crook, R.; Farrer, M.; Houlden, H.; Isaacs, A.; Lincoln, S.; Onstead, L.; Hardy, J.; Wittenberg, L.; Dodd, P.; Webb, S.; Hayward, N.; Tannenberg, T.; Andreadis, A.; Hallupp, M.; Schofield, P.; Dark, F.; Hutton, M. Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Ann. Neurol., 1997, 42, 794-8.
9. Froelich, S.; Basun, H.; Forsell, C.; Lilius, L.; Axelman, K.; Andreadis, A.; Lannfelt, L. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. Am. J. Med. Genet., 1997, 74, 380-5.
10. Basun, H.; Almkvist, O.; Axelman, K.; Brun, A.; Campbell, T.A.; Collinge, J.; Forsell, C.; Froelich, S.; Wahlund, L.O.; Wetterberg, L.; Lannfelt, L. Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Arch. Neurol., 1997, 54, 539-44.
11. Heutink, P.; Stevens, M.; Rizzu, P.; Bakker, E.; Kros, J.M.; Tibben, A.; Niermeijer, M.F.; van Duijn, C.M.; Oostra, B.A.; van Swieten, J.C. Hereditary frontotemporal dementia is linked to chromosome 17q21-q22: a genetic and clinicopathological study of three Dutch families. Ann. Neurol., 1997, 41, 150-9.
12. Bird, T.D.; Wijsman, E.M.; Nochlin, D.; Leehey, M.; Sumi, S.M.; Payami, H.; Poorkaj, P.; Nemens, E.; Rafkind, M.; Schellenberg, G.D. Chromosome 17 and hereditary dementia: linkage studies in three non-Alzheimer families and kindreds with late-onset FAD. Neurology, 1997, 48, 949-54.
13. Yamaoka, L.H.; Welsh-Bohmer, K.A.; Hulette, C.M.; Gaskell, P.C. Jr; Murray, M.; Rimmler, J.L.; Helms, B.R.; Guerra, M.; Roses, A.D.; Schmechel, D.E.; Pericak-Vance, M.A. Linkage of frontotemporal dementia to chromosome 17: clinical and neuropathological characterization of phenotype. Am. J. Hum. Genet., 1996, 59, 1306-12.
14. Foster, N.L.; Wilhelmsen, K.; Sima, A.A.; Jones, M.Z.; D'Amato, C.J.; Gilman, S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference Participants. Ann. Neurol., 1997, 41, 706-15.
15. Hutton, M.; Lendon, C.L.; Rizzu, P.; Baker, M.; Froelich, S.; Houlden, H.; Pickering-Brown, S.; Chakraverty, S.; Isaacs, A.; Grover, A.; Hackett, J.; Adamson, J.; Lincoln, S.; Dickson, D.; Davies, P.; Petersen, R.C.; Stevens, M.; de Graaff, E.; Wauters, E.; van Baren, J.; Hillebrand, M.; Joosse, M.; Kwon, J.M.; Nowotny, P.; Che, L.K.; Norton, J.; Morris, J.C.; Reed, L.A.; Trojanowski, J.; Basun, H.; Lannfelt, L.; Neystat, M.; Fahn, S.; Dark, F.; Tannenberg, T.; Dodd, P.R.; Hayward, N.; Kwok, J.B.; Schofield, P.R.; Andreadis, A.; Snowden, J.; Craufurd, D.; Neary, D.; Owen, F.; Oostra, B.A.; Hardy, J.; Goate, A.; van Swieten, J.; Mann, D.; Lynch, T.; Heutink, P. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 1998, 393, 702-5.
16. Poorkaj, P.; Bird, T.D.; Wijsman, E.; Nemens, E.; Garruto, R.M.; Anderson, L.; Andreadis, A.; Wiederholt, W.C.; Raskind, M.; Schellenberg, G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol., 1998, 43, 815-25.
17. Spillantini, M.G.; Murrell, J.R.; Goedert, M.; Farlow, M.R.; Klug, A.; Ghetti, B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA., 1998, 95, 7737-41.
18. Goedert, M.; Spillantini, M.G.; Potier, M.C.; Ulrich, J.; Crowther, R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J., 1989, 8, 393-9.
19. Kaivorinne, A.L.; Krüger, J.; Kuivaniemi K.; Tuominen, H.; Moilanen, V.; Majamaa, K.; Remes, A.M. Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland. BMC Neurol., 2008, 8, 48.
20. Rizzu, P.; Van Swieten, J.C.; Joosse, M.; Hasegawa, M.; Stevens, M.; Tibben, A.; Niermeijer, M.F.; Hillebrand, M.; Ravid, R.; Oostra, B.A.; Goedert, M.; van Duijn, C.M.; Heutink, P. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am. J. Hum. Genet., 1999, 64, 414-21.
21. Binetti, G.; Nicosia, F.; Benussi, L.; Ghidoni, R.; Feudatari, E.; Barbiero, L.; Signorini, S.; Villa, A.; Mattioli, F.; Zanetti, O.; Alberici, A. Prevalence of TAU mutations in an Italian clinical series of familial frontotemporal patients. Neurosci. Lett., 2003, 338, 85-7.
22. Dumanchin, C.; Camuzat, A.; Campion, D.; Verpillat, P.; Hannequin, D.; Dubois, B.; Saugier-Veber, P.; Martin, C.; Penet, C.; Charbonnier, F., Agid, Y.; Frebourg, T.; Brice, A. Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism. Hum. Mol. Genet., 1998, 7, 1825-9.
23. Houlden, H.; Baker, M.; Adamson, J.; Grover, A.; Waring, S.; Dickson, D.; Lynch, T.; Boeve, B.; Petersen, R.C.; Pickering-Brown, S.; Owen, F.; Neary, D.; Craufurd, D.; Snowden, J.; Mann, D.; Hutton, M. Frequency of tau mutations in three series of non- Alzheimer's degenerative dementia. Ann. Neurol., 1999, 46, 243-8.
24. Morris, H.R.; Khan, M.N.; Janssen, J.C.; Brown, J.M.; Perez-Tur, J.; Baker, M.; Ozansoy, M.; Hardy, J.; Hutton, M.; Wood, N.W.; Lees, A.J.; Revesz, T.; Lantos, P.; Rossor, M.N. The genetic and pathological classification of familial frontotemporal dementia. Arch. Neurol., 2001, 58, 1813-6.
25. Poorkaj, P.; Grossman, M.; Steinbart, E.; Payami, H.; Sadovnick, A.; Nochlin, D.; Tabira, T.; Trojanowski, J.Q.; Borson, S.; Galasko, D.; Reich, S.; Quinn, B.; Schellenberg, G.; Bird, T.D. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch. Neurol., 2001, 58, 383-7.
26. Pickering-Brown, S.M.; Rollinson, S.; Du Plessis, D.; Morrison, K.E.; Varma, A.; Richardson, A.M.T; Neary, D.; Snowden, J.S.; Mann, D.M.A. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain, 2008, 131, 721-731.
27. Momeni, P.; Wickremaratchi, M.M.; Bell, J.; Arnold, R.; Beer, R.; Hardy, J.; Revesz, T.; Neal, J.W.; Morris, H.R. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. Clin. Neurol. Neurosurg., 2010, 11.
28. Hayashi, S.; Toyoshima, Y.; Hasegawa, M.; Umeda, Y.; Wakabayashi, K.; Tokiguchi, S.; Iwatsubo, T.; Takahashi, H. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann. Neurol., 2002, 51, 525-30.
29. Kertesz, A.; Kawarai, T.; Rogaeva, E.; St George-Hyslop, P.; Poorkaj, P.; Bird, T.D.; Munoz, D.G. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology, 2000, 54, 818-27.
30. Rademakers, R.; Cruts, M.; Dermaut, B.; Sleegers, K.; Rosso, S.M.; Van den Broeck, M.; Backhovens, H.; van Swieten, J.; van Duijn, C.M.; Van Broeckhoven, C. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol. Psychiatry., 2002, 7, 1064-74.
31. Rosso, S.M.; Kamphorst, W.; de Graaf, B.; Willemsen, R.; Ravid, R.; Niermeijer, M.F.; Spillantini, M.G.; Heutink, P. van Swieten, J.C. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain., 2001, 124, 1948-57.
32. Mackenzie, I.R.; Baker, M.; Pickering-Brown, S.; Hsiung, G.Y.; Lindholm, C.; Dwosh, E.; Gass, J.; Cannon, A.; Rademakers, R.; Hutton, M.; Feldman, H.H. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain., 2006, 129, 3081-90.
33. Curcio, S.A.; Kawarai, T.; Paterson, A.D., Maletta, R.G.; Puccio, G.; Perri, M.; Di Natale, M.; Palermo, S.; Foncin, J.F.; Hyslop, P.H.; Bruni, A.C. A large Calabrian kindred segregating frontotemporal dementia. J. Neurol., 2002, 249, 911-22.
34. Baker, M.; Mackenzie, I.R.; Pickering-Brown, S.M.; Gass, J.; Rademakers, R.; Lindholm, C.; Snowden, J.; Adamson, J.; Sadovnick, A.D.; Rollinson, S.; Cannon, A.; Dwosh, E.; Neary, D.; Melquist, S.; Richardson, A.; Dickson, D.; Berger, Z.; Eriksen, J.; Robinson, T.; Zehr, C.; Dickey, C.A.; Crook, R.; McGowan, E.; Mann, D.; Boeve, B.; Feldman, H.; Hutton, M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 2006, 442, 916-9.
35. Cruts, M.; Gijselinck, I.; van der Zee, J.; Engelborghs, S.; Wils, H.; Pirici, D.; Rademakers, R.; Vandenberghe, R.; Dermaut, B.; Martin, J.J.; van Duijn, C.; Peeters, K.; Sciot, R.; Santens, P.; De Pooter, T.; Mattheijssens, M.; Van den Broeck, M.; Cuijt, I.; Vennekens, K.; De Deyn, P.P.; Kumar-Singh, S.; Van Broeckhoven, C. Null mutations in progranulin cause ubiquitin-positive frontotemporal lobar degenerationlinked to chromosome 17q21. Nature, 2006, 442, 920-4.
36. Neumann, M.; Sampathu, D.M.; Kwong, L.K.; Truax, A.C.; Micsenyi, M.C.; Chou, T.T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C.M.; McCluskey, L.F.; Miller, B.L.; Masliah, E.; Mackenzie, I.R.; Feldman, H.; Feiden, W.; Kretzschmar, H.A.; Trojanowski, J.Q.; Lee, V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 2006, 314, 130-3.
37. Borroni, B.; Archetti, S.; Alberici, A.; Agosti, C.; Gennarelli, M.; Bigni, B.; Bonvicini, C.; Ferrari, M.; Bellelli, G.; Galimberti, D.; Scarpini, E.; Di Lorenzo, D.; Caimi, L.; Caltagirone, C.; Di Luca, M.; Padovani, A. Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series. Neurogenetics, 2008, 9, 197-205.
38. Bruni, A.C.; Momeni, P.; Bernardi, L.; Tomaino, C.; Frangipane, F.; Elder, J.; Kawarai, T.; Sato, C.; Pradella, S.; Wakutani, Y.; Anfossi, M.; Gallo, M.; Geracitano, S.; Costanzo, A.; Smirne, N.; Curcio, S.A.; Mirabelli, M.; Puccio, G.; Colao, R.; Maletta, R.G.; Kertesz, A.; St George-Hyslop, P.; Hardy, J.; Rogaeva, E. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology, 2007, 69, 140-7.
39. Krüger, J.; Kaivorinne, A.L.; Udd, B.; Majamaa, K.; Remes, A.M. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur. J. Neurol., 2009, 16, 27-30.
40. Guerreiro, R.J.; Santana, I.; Bras, J.M.; Revesz, T.; Rebelo, O.; Ribeiro, M.H.; Santiago, B.; Oliveira, C.R.; Singleton, A.; Hardy, J. Novel progranulin mutation: screening for PGRN mutations in a Portuguese series of FTD/CBS cases. Mov. Disord., 2008, 23, 1269-73.
41. van der Zee, J.; Le Ber, I.; Maurer-Stroh, S.; Engelborghs Gijselinck I.; Camuzat, A.; Brouwers, N.; Vandenberghe, R.; Sleegers K.; Hannequin, D.; Dermaut B.; Schymkowitz J.; Campion D.; Santen, P.; Martin J.J; Lacomblez L.; De Pooter T.; Peeters, K.; Mattheijssens M.; Vercelletto M.; Van den Broeck, M.; Cruts M.; De Deyn P.P.; Rousseau F.A.; Van Broeckhoven C. Mutations Other Than Null Mutations Producing a Pathogenic Loss of Progranulin in Frontotemporal Dementia. Human Mutation. 2007, 28, 416.
42. Gass, J.; Cannon, A.; Mackenzie, I.R.; Boeve, B.; Baker, M.; Adamson, J.; Crook, R.; Melquist, S.; Kuntz, K.; Petersen, R.; Josephs, K., Pickering- Brown, S.M.; Graff-Radford, N.; Uitti, R.; Dickson, D.; Wszolek, Z.; Gonzalez, J.; Beach, T.G.; Bigio, E.; Johnson, N.; Weintraub, S.; Mesulam, M.; White, C.L.; Woodruff, B.; Caselli, R.; Hsiung, G.Y.; Feldman, H.; Knopman, D.; Hutton, M.; Rademakers, R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet., 2006, 15, 2988-3001.
43. Le Ber, I.; van der Zee, J.; Hannequin, D.; Gijselinck, I.; Campion, D.; Puel, M.; Laquerrière, A.; De Pooter, T.; Camuzat, A.; Van den Broeck, M.; Dubois, B.; Sellal, F.; Lacomblez, L.; Vercelletto, M.; Thomas-Antérion, C.; Michel, B.F.; Golfier, V.; Didic, M.; Salachas, F.; Duyckaerts, C.; Cruts, M.; Verpillat, P.; Van Broeckhoven, C.; Brice, A. Progranulin null mutations in both sporadic and familial frontotemporal dementia. Human mutation, 2007, 28, 846-55.
44. Boeve, B.F.; Hutton, M. Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch. Neurol., 2008, 65, 460-4.
45. Cruts, M.; Van Broeckhoven, C. Loss of progranulin function in frontotemporal lobar degeneration. Trends Genet., 2008, 24, 186-94.
46. Gijselinck, I.; Van Broeckhoven, C.; Cruts, M. Granulin mutations associated with frontotemporal lobar degeneration and related disorders: an update. Hum. Mutat., 2008, 29, 1373-86.
47. Skibinski, G.; Parkinson, N.J.; Brown, J.M.; Chakrabarti, L.; Lloyd, S.L.; Hummerich, H.; Nielsen, J.E.; Hodges, J.R.; Spillantini, M.G.; Thusgaard, T.; Brandner, S.; Brun, A.; Rossor, M.N.; Gade, A.; Johannsen, P.; Sørensen, S.A.; Gydesen, S.; Fisher, E.M.; Collinge, J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet., 2005, 37, 806-8.
48. van der Zee J.; Urwin, H.; Engelborghs, S.; Bruyland, M.; Vandenberghe, R.; Dermaut, B.; De Pooter, T.; Peeters, K.; Santens, P.; De Deyn P.P.; Fisher E.M.; Collinge J.; Isaacs A.M.; Van Broeckhoven C. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet., 2008, 17, 313-22.
49. Momeni, P.; Rogaeva, E.; Van Deerlin, V.; Yuan, W.; Grafman, J.; Tierney, M.; Huey, E.; Bell, J.; Morris, C.M.; Kalaria, R.N.; van Rensburg, S.J.; Niehaus, D.; Potocnik, F.; Kawarai, T.; Salehi-Rad, S.; Sato, C.; St George-Hyslop, P.; Hardy, J. Genetic variability in CHMP2B and frontotemporal dementia. Neurodegener. Dis., 2006, 3, 129-33.
50. Watts, G.D.; Wymer, J.; Kovach, M.J.; Mehta, S.G.; Mumm, S.; Darvish, D.; Pestronk, A.; Whyte, M.P.; Kimonis, V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet., 2004, 36, 377-81.
51. Sreedharan, J.; Blair, I.P.; Tripathi, V.B.; Hu, X.; Vance, C.; Rogelj, B.; Ackerley, S.; Durnall, J.C.; Williams, K.L.; Buratti, E.; Baralle, F.; de Belleroche, J.; Mitchell, J.D.; Leigh, P.N.; Al- Chalabi, A.; Miller, C.C.; Nicholson, G.; Shaw, C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science, 2008, 319, 1668-72.
52. Kabashi, E.; Valdmanis, P.N.; Dion, P.; Spiegelman, D.; McConkey, B.J.; Vande Velde, C.; Bouchard, J.P.; Lacomblez, L.; Pochigaeva, K.; Salachas, F.; Pradat, P.F.; Camu, W.; Meininger, V.; Dupre, N.; Rouleau, G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet., 2008, 40, 572-4.
53. Guerreiro, R.J.; Schymick, J.C.; Crews, C.; Singleton, A.; Hardy, J.; Traynor, B.J. TDP-43 is not a common cause of sporadic amyotrophic lateral sclerosis. PLoS One, 2008, 3, 2450.
54. Daoud, H.; Valdmanis, P.N.; Kabashi, E.; Dion, P.; Dupré, N.; Camu, W.; Meininger, V.; Rouleau, G.A. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet., 2009, 46, 112-4.
55. Benajiba, L.; Le Ber, I.; Camuzat, A.; Lacoste, M.; Thomas- Anterion, C.; Couratier, P.; Legallic, S.; Salachas, F.; Hannequin, D.; Decousus, M.; Lacomblez, L.; Guedj, E.; Golfier, V.; Camu, W.; Dubois, B.; Campion, D.; Meininger, V.; Brice, A. French Clinical and Genetic Research Network on Frontotemporal Lobar Degeneration/Frontotemporal Lobar Degeneration with Motoneuron Disease. Ann. Neurol., 2009, 65, 470-3.
56. Borroni, B.; Bonvicini, C.; Alberici, A.; Buratti, E.; Agosti, C.; Archetti, S.; Papetti, A.; Stuani, C.; Di Luca, M.; Gennarelli, M.; Padovani, A. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat., 2009, 30, 974-83.
57. Borroni, B.; Archetti, S.; Del Bo, R.; Papetti, A.; Buratti, E.; Bonvicini, C.; Agosti, C.; Cosseddu, M.; Turla, M.; Di Lorenzo, D.; Comi, G.P.; Gennarelli, M.; Padovani, A. TARDBP Mutations in Frontotemporal Lobar Degeneration: Frequency, Clinical Features, and Disease Course. Rejuvenation Res., 2010 Epub.
58. Vance. C.; Rogelj B.; Hortobágyi T.; De Vos K.J.; Nishimura A.L.; Sreedharan J.; Hu X.; Smith B.; Ruddy D.; Wright P.; Ganesalingam J.; Williams K.L.; Tripathi V.; Al-Saraj S.; Al-Chalabi, A.; Leigh P.N.; Blair I.P.; Nicholson G.; de Belleroche J.; Gallo J.M.; Miller C.C.; Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science, 2009, 323, 1208-11.
59. Van Langenhove, T.; van der Zee, J.; Sleegers, K.; Engelborghs, S.; Vandenberghe, R.; Gijselinck, I.; Van den Broeck, M.; Mattheijssens, M.; Peeters, K.; De Deyn, P,P.; Cruts, M.; Van Broeckhoven, C. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology, 2010, 74, 366-71.
60. Baker, M.; Litvan, I.; Houlden, H.; Adamson, J.; Dickson, D.; Perez-Tur, J.; Hardy, J.; Lynch, T.; Bigio, E.; Hutton, M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet., 1999, 8, 711-5.
61. Pittman, A.M.; Myers, A.J.; Abou-Sleiman, P.; Fung, H.C.; Kaleem, M.; Marlowe, L.; Duckworth, J.; Leung, D.; Williams, D.; Kilford, L.; Thomas, N.; Morris, C.M.; Dickson, D.; Wood, N.W.; Hardy, J.; Lees, A.J.; de Silva, R. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet., 2005, 42, 837-46.
62. Bernardi, L.; Maletta, R.G.; Tomaino, C.; Gallo, M.; Geracitano, S.; Costanzo, A.; Colao, R.; Puccio, G.; Frangipane, F.; Curcio, S.A.; Mirabelli, M.; Smirne, N.; Iapaolo, D.; Maletta, R.G.; Bruni, A.C. The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol. Aging., 2006, 27, 702-9.
63. Sobrido, M.J.; Miller, B.L.; Havlioglu, N.; Zhukareva, V.; Jiang, Z.; Nasreddine, Z.S.; Lee, V.M.; Chow, T.W.; Wilhelmsen, K.C.; Cummings, J.L.; Wu, J.Y.; Geschwind, D.H. Novel tau polymorphisms, tau haplotypes, and splicing in familial and sporadic frontotemporal dementia. Arch. Neurol., 2003, 60, 698-702.
64. Hughes, A.; Mann, D.; Pickering-Brown, S. Tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp. Neurol., 2003, 181, 12-6.
65. Borroni, B.; Yancopoulou, D.; Tsutsui, M.; Padovani, A.; Sawcer, S.J.; Hodges, J.R.; Spillantini, M.G. Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch. Neurol., 2005, 62, 1419-22.
66. Laws, S.M.; Friedrich, P.; Diehl-Schmid, J.; Müller, J.; Ibach, B.; Bäuml, J.; Eisele, T.; Förstl, H.; Kurz, A.; Riemenschneider, M. Genetic analysis of MAPT haplotype diversity in frontotemporal dementia. Neurobiol. Aging, 2008, 29, 1276-8.
67. Laws, S.M.; Perneczky, R.; Drzezga, A.; Diehl-Schmid, J.; Ibach, B.; Bäuml, J.; Eisele, T.; Förstl, H.; Kurz, A.; Riemenschneider, M. Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia. The American journal of psychiatry, 2007, 164, 1577-84.
68. Borroni, B., Perani, D., Agosti, C., Anchisi, D., Paghera, B., Archetti S.,Alberici A., Di Luca M., Padovani A. Tau haplotype influences cerebral perfusion pattern in frontotemporal lobar de generation and related disorders. Acta. Neurol. Scand., 2008, 117, 359-366.
69. Kwok, J.B.; Teber, E.T.; Loy, C.; Hallupp, M.; Nicholson, G.; Mellick, G.D.; Buchanan, D.D.; Silburn, P.A.; Schofield; P.R. Tau haplotypes regulate transcription and are associated with Parkinson's disease. Ann Neurol., 2004, 55, 329-334.
70. Galimberti, D.; Fenoglio, C.; Cortini, F.; Serpente, M.; Venturelli, E.; Villa, C.; Clerici, F.; Marcone, A.; Benussi, L.; Ghidoni, R.; Gallone, S.; Scalabrini, D., Restelli, I.; Boneschi, F.M.; Cappa, S.; Binetti, G.; Mariani, C.; Rainero, I.; Giordana, M.T.; Bresolin, N.; Scarpini, E. GRN Variability Contributes to Sporadic Frontotemporal Lobar Degeneration. J. Alzheimers Dis., 2010, 19, 171-7.
71. Brouwers, N.; Sleegers, K.; Engelborghs, S.; Maurer-Stroh, S.; Gijselinck, I.; van der Zee, J.; Pickut, B.A.; Van den Broeck, M.; Mattheijssens, M.; Peeters, K.; Schymkowitz, J.; Rousseau, F.; Martin, J.J.; Cruts, M.; De Deyn, P.P.; Van Broeckhoven, C. Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology, 2008, 71, 656-64.
72. Viswanathan, J.; Makinen, P.; Helisalmi, S.; Haapasalo, A.; Soininen, H. An association study between granulin gene polymorphisms and Alzheimer's disease in Finnish population. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 2008, 747-750.
73. Sleegers, K.; Brouwers, N.; Maurer-Stroh, S.; van Es, M.A.; Van Damme, P.; van Vught, P.W.; van der Zee, J.; Serneels, S.; De Pooter, T.; Van den Broeck, M.; Cruts, M.; Schymkowitz, J.; De Jonghe, P.; Rousseau, F.; van den Berg, L.H.; Robberecht, W.; Van Broeckhoven, C. Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology, 2008, 71, 253-9.
74. Dickson, D.W.; Baker, M.; Rademakers, R. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener. Dis., 2010, 7, 170-4.
75. Rademakers, R.; Eriksen, J.L.; Baker, M.; Robinson, T.; Ahmed, Z.; Lincoln, S.J.; Finch, N.; Rutherford, N.J.; Crook, R.J.; Josephs, K.A.; Boeve, B.F.; Knopman, D.S.; Petersen, R.C.; Parisi, J.E.; Caselli, R.J.; Wszolek, Z.K.; Uitti, R.J.; Feldman, H.; Hutton, M.L.; Mackenzie, I.R.; Graff-Radford, N.R.; Dickson, D.W. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet., 2008, 17, 3631-3642.
76. Rollinson, S.; Rizzu, P.; Sikkink, S.; Baker, M.;Halliwell, N.; Snowden, J.; Traynor, B.J.; Ruano, D.; Cairns, N.; Rohrer, J.D.; Mead Collinge, J.; Rossor, M.; Akay, E.; Guerreiro, R.; Rademakers, R.; Morrison, K.E.; Pastor, P.; Alonso, E.; Martinez-Lage, P.; Graff-Radford, N.; Neary, D.; Heutink, P.; Mann, D.M.; Van Swieten, J.; Pickering- Brown S.M. Ubiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration. Neurobiol. Aging., 2009, 30, 656-665.
77. Simón-Sánchez, J.; Seelaar, H.; Bochdanovits, Z.; Deeg, D.J.; van Swieten, J.C.; Heutink, P. Variation at GRN 3'-UTR rs5848 is not associated with a risk of frontotemporal lobar degeneration in Dutch population. PLoS One, 2009, 4, e7494.
78. Galimberti, D.; Scarpini, E. Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. Int. J. Exp. Med., 2010, 15, 129-43
79. Schumacher, A.; Friedrich, P.; Diehl, J.; Ibach, B.; Schoepfer- Wendels, A.; Mueller, J.C.; Konta, L.; Laws, S.M.; Kurz, A.; Foerstl, H.; Riemenschneider, M. No association of common VCP variants with sporadic frontotemporal dementia. Neurobiol. Aging, 2009, 30, 333-5.
80. Cantoni, C.; Fenoglio, C.; Cortini, F.; Venturelli, E.; Villa, C.; Clerici, F.; Marcone, A.; Benussi, L.; Ghidoni, R.; Gallone, S.; Scalabrini, D.; Franceschi, M.; Cappa, S.; Binetti, G.; Marian, i C.; Rainero, I.; Giordana, M.T.; Bresolin, N.; Scarpini, E.; Galimberti, D. FUS/TLS genetic variability in sporadic frontotemporal lobar degeneration. J. Alzheimers Dis., 2010, 19, 1317-22.
81. Schumacher, A.; Friedrich, P.; Diehl-Schmid, J.; Ibach, B.; Perneczky, R.; Eisele, T.; Vukovich, R.; Foerstl, H.; Riemenschneider, M. No association of TDP-43 with sporadic frontotemporal dementia. Neurobiol. Aging, 2009, 30, 157-9.
82. Ghanim, M.; Guillot-Noel, L.; Pasquier, F.; Jornea, L.; Deramecourt, V.; Dubois, B.; Le Ber, I.; Brice, A. The French Research Network on FTD and FTD/MND. CHMP2B mutations are rare in French families with frontotemporal lobar degeneration. J. Neurol., 2010.
83. Grehan, S.; Tse, E.; Taylor, J.M. Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. J. Neurosci., 2001, 21, 812-22.
84. Pitas, R.E.; Boyles, J.K.; Lee, S.H.; Hui, D.; Weisgraber, K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J. Biol. Chem., 1987, 262, 14352-60.
85. Mahley, R.W.; Weisgraber, K.H.; Huang, Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. USA., 2006, 103, 5644-51.
86. Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.E.; Gaskell, P.C.; Small, G.W.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 1993, 261, 921-3.
87. Farrer, L.A.; Abraham, C.R.; Volicer, L.; Foley, E.J.; Kowall, N.W.; McKee, A.C.; Wells, J.M. Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp. Neurol., 1995, 136, 162-70.
88. Gustafson, L.; Abrahamson, M.; Grubb, A.; Nilsson, K.; Fex, G. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement. Geriatr. Cogn. Disord., 1997, 8, 240-3.
89. Srinivasan, R.; Davidson, Y.; Gibbons, L.; Payton, A.; Richardson, A.M.; Varma, A.; Julien, C.; Stopford, C.; Thompson, J.; Horan, M.A.; Pendleton, N.; Pickering-Brown, S.M.; Neary, D.; Snowden, J.S.; Mann, D.M. The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J. Neurol. Neurosurg. Psychiatry, 2006, 77, 154-8.
90. Rosso, S.M.; Roks, G.; Cruts, M.; van Broeckhoven, C.; Heutink, P.; van Duijn, C.M.; van Swieten, J.C. Apolipoprotein E4 in the temporal variant of frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry, 2002, 72, 820.
91. Fabre, S.F.; Forsell, C.; Viitanen, M.; Sjögren, M.; Wallin, A.; Blennow, K.; Blomberg, M.; Andersen, C.; Wahlund, L.O.; Lannfelt, L. Clinic-based cases with frontotemporal lobar degenerationshow increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp. Neurol., 2001, 168, 413-8.
92. Lehmann, D.J.; Smith, A.D.; Combrinck, M.; Barnetson, L.; Joachim, C. Apolipoprotein E epsilon2 may be a risk factor for sporadic frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry, 2000, 69, 404-405.
93. Masullo, C.; Daniele, A.; Fazio, V.M.; Seripa, D.; Gravina, C.; Filippini, V.; Grossi, D.; Fragassi, N.; Nichelli, P.; Leone, M.; Gainotti, G. The Apolipoprotein E genotype in patients affected by syndromes with focal cortical atrophy. Neurosci. Lett., 2001, 303, 87-90.
94. Verpillat, P.; Camuzat, A.; Hannequin, D.; Thomas- Anterion, C.; Puel, M.; Belliard, S.; Dubois, B.; Didic, M.; Lacomblez, L.; Moreaud, O.; Golfier, V.; Campion, D.; Brice, A.; Clerget-Darpoux, F. Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis. Eur. J. Hum. Genet., 2002, 10, 399-405.
95. Verpillat, P.; Camuzat, A.; Hannequin, D.; Thomas-Anterion, C.; Puel, M.; Belliard, S.; Dubois, B.; Didic, M.; Michel, B.F.; Lacomblez L.; Moreaud, O.; Sellal, F.; Golfier, V.; Campion, D.; Clerget-Darpoux, F.; Brice, A. Association between the extended tau haplotype and frontotemporal dementia. Arch. Neurol., 2002, 59, 935-9.
96. Mann, D.M.; McDonagh, A.M.; Pickering-Brown, S.M.; Kowa, H.; Iwatsubo, T. Amyloid beta protein deposition in patients with frontotemporal lobar degeneration: relationship to age and apolipoprotein E genotype. Neurosci. Lett., 2001, 304, 161-4.
97. Boccardi, M.; Sabattoli, F.; Testa, C.; Beltramello, A.; Soininen, H.; Frisoni, G.B. APOE and modulation of Alzheimer's and frontotemporal dementia. Neurosci. Lett., 2004, 356, 167-70.
98. Agosta, F.; Vossel, K.A.; Miller, B.L.; Migliaccio, R.; Bonasera, S.J.; Filippi, M.; Boxel, A.L.; Karyndas, A.; Possin, K.L.; Gorno-Tempini, M.L. Apolipoprotein E4 is associated with diseasespecific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc. Natl. Acad. Sci. USA, 2009, 106, 2018-22.
99. Borroni, B., Perani, D., Archetti, S., Agosti, C., Paghera, B., Bellelli, G., Di Luca, M., Padovani, A., 2006. Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration. BMC Neurol., 2006, 6, 31.
100. Engelborghs, S.; Dermaut, B.; Mariën, P.; Symons, A.; Vloeberghs, E.; Maertens, K.; Somers, N.; Goeman, J.; Rademakers, R.; Van den Broeck, M.; Pickut, B.; Cruts, M.; Van Broeckhoven, C.; De Deyn, P.P. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiol. Aging., 2006, 27, 285-92.
101. Minthon, L.; Hesse, C.; Sjogren, M.; Englund, E.; Gustafson, L.; Blennow, K. The apolipoprotein E epsilon4 allele frequency is normal in frontotemporal dementia, but correlates with age at onset of disease. Neurosci. Lett., 1997, 226, 65-67.
102. Borroni, B.; Grassi, M.; Agosti, C.; Premi, E.; Archetti, S.; Alberici, A.; Bellelli, G.; Caimi, L.; Di Luca, M.; Padovani, A. Establishing short-term prognosis in Frontotemporal Lobar Degeneration spectrum: role of genetic background and clinical phenotype. Neurobiol. Aging., 2010, 31, 270-9.
103. Van Deerlin, V.M.; Sleiman, P.M.; Martinez-Lage, M.; Chen- Plotkin, A.; Wang, L.S.; Graff-Radford, N.R.; Dickson, D.W.; Rademakers, R.; Boeve, B.F.; Grossman, M.; Arnold, S.E.; Mann, D.M.; Pickering-Brown, S.M.; Seelaar, H.; Heutink, P.; van Swieten, J.C.; Murrell, J.R.; Ghetti, B.; Spina, S.; Grafman, J.; Hodges, J.; Spillantini, M.G.; Gilman, S.; Lieberman, A.P.; Kaye, J.A.; Woltjer, R.L.; Bigio, E.H.; Mesulam, M.; Al-Sarraj, S.; Troakes, C.; Rosenberg, R.N.; White, C.L.; Ferrer, I.; Lladó, A.; Neumann, M.; Kretzschmar, H.A.; Hulette, C.M.; Welsh-Bohmer, K.A.; Miller, B.L.; Alzualde, A.; de Munain, A.L.; McKee, A.C.; Gearing, M.; Levey, AI.; Lah, J.J.; Hardy, J.; Rohrer, J.D.; Lashley, T.; Mackenzie, I.R.; Feldman, H.H.; Hamilton, R.L.; Dekosky, S.T.; van der Zee, J.; Kumar-Singh, S.; Van Broeckhoven, C.; Mayeux, R.; Vonsattel, J.P.; Troncoso, J.C.; Kril, J.J.; Kwok, J.B.; Halliday, G.M.; Bird, T.D.; Ince, P.G.; Shaw, P.J.; Cairns, N.J.; Morris, J.C.; McLean, C.A.; DeCarli, C.; Ellis, W.G.; Freeman, S.H.; Frosch, M.P.; Growdon, J.H.; Perl, D.P.; Sano, M.; Bennett, D.A.; Schneider, J.A.; Beach, T.G.; Reiman, E.M.; Woodruff, B.K.; Cummings, J.; Vinters, H.V.; Miller, C.A.; Chui, H.C.; Alafuzoff, I.; Hartikainen, P.; Seilhean, D.; Galasko, D.; Masliah, E.; Cotman, C.W.; Tuñón, M.T.; Martínez, M.C.; Munoz, D.G.; Carroll, S.L.; Marson, D.; Riederer, P.F.; Bogdanovic, N.; Schellenberg, G.D.; Hakonarson, H.; Trojanowski, J.Q.; Lee, V.M. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet., 2010, 42, 234-239.
104. Morita, M.; Al-Chalabi, A.; Andersen, P.M.; Hosler, B.; Sapp, P.; Englund, E.; Mitchell, J.E.; Habgood, J.J.; de Belleroche, J.; Xi, J.; ngjaroenprasert, W.; Horvitz, H.R.; Gunnarsson, L.G.; Brown Jr, R.H. A locuson chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology, 2006, 66, 839-844.
105. Vance, C.; Al-Chalabi, A.; Ruddy, D.; Smith, B.N.; Hu X.; Sreedharan, J.; Siddique, T.; Schelhaas, H.J.; Kusters, B.; Troost, D.; Baas, F.; de Jong, V.; Shaw, C.E.: Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain, 2006, 129, 868-76.
106. Le Ber, I.; Camuzat, A.; Berger, E.; Hannequin, D.; Laquerrière, A.; Golfier, V.; Seilhean, D.; Viennet, G.; Couratier, P.; Verpillat, P.; Heath, S.; Camu, W.; Martinaud, O.; Lacomblez, L.; Vercel letto, M.; Salachas, F.; Sellal, F.; Didic, M.; Thomas-Anterion, C.; Puel, M.;
107. Arai, T.; Nonaka, T.; Hasegawa, M.; Akiyama, H.; Yoshida, M.; Hashizume, Y.; Tsuchiya, K.; Oda, T.; Ikeda, K. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci. Lett., 2003, 342, 41-44.
108. Schwartz, A.L.; Ciechanover, A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med., 1999, 50, 57-74.
109. Petrucelli, L.; Dawson, T.M. Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system. Ann. Med., 2004, 36, 315-320.
110. Venturelli, E.; Villa, C.; Fenoglio, C.; Clerici, F.; Marcone, A.; Benussi, L.; Ghidoni, R.; Gallone, S.; Scalabrini, D.; Cortini, F.; Fumagalli, G.; Cappa, S.; Binetti, G.; Franceschi, M.; Rainero, I.; Giordana, M.T.; Mariani, C.; Bresolin, N.; Scarpini, E.; Galimberti, D.:Is KIF24 a genetic risk factor for Frontotemporal Lobar Degeneration?. Neurosci. Lett., 2010, 482, 240-4.
111. Miki, H.; Setou, M.; Kaneshiro, K.; Hirokawa, N. All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. U.S.A., 2001, 98, 7004-7011.
112. Kurz, T.; Ö zlü, N.; Rudolf, F. The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature., 2005, 435, 1257-1261.
113. Villa, C.; Venturelli, E.; Fenoglio, C.; Clerici, F.; Marcone, A.; Benussi, L.; Gallone, S.; Scalabrini, D.; Cortini, F.; Serpente, M.; Martinelli Boneschi, F.; Cappa, S.; Binetti, G.; Mariani, C.; Rainero, I.; Giordana, M.T.; Bresolin, N.; Scarpini, E.; Galimberti, D. DCUN1D1 is a risk factor for frontotemporal lobar degeneration. Eur. J. Neurol., 2009, 16, 870-3
114. [Collinge, J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci., 2001, 24, 519-550.
115. Kovacs, G.G.; Trabattoni, G.; Hainfellner, J.A. Mutations of the prion protein gene phenotypic spectrum. J. Neurol., 2002, 249, 1567-1582.
116. Li, X.; Rowland, L.P.; Mitsumoto, H.; Przedborski, S.; Bird, T.D.; Schellenberg, G.D.; Peskind, E.; Johnson, N.; Siddique, T.; Mesulam, M.M.; Weintraub, S.; Mastrianni, J.A. Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann. Neurol., 2005, 58, 858-864.
117. Bounhar, Y.; Zhang, Y.; Goodyer, C.G.; LeBlanc, A. Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem., 2001, 276, 39145-39149.
118. Rohrer, J.D.; Mead, S.; Omar, R.; Poulter, M.; Warren, J.D.; Collinge, J.; Rossor, M.N. Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes. Ann. Neurol., 2006, 60, 616.
119. Rosenstein, J.M.; Krum J.M. New roles for VEGF in nervous tissue-- beyond blood vessels. Exp. Neurol., 2004, 187, 246-53.
120. Storkebaum, E.; Lambrechts, D.; Dewerchin, M.; Moreno- Murciano, M.P.; Appelmans, S.; Oh, H.; Van Damme, P.; Rutten, B.; Man, W.Y.; De Mol, M.; Wyns, S.; Manka, D.; Vermeulen, K.; Van Den Bosch, L.; Mertens, N.; Schmitz, C.; Robberecht, W.; Conway, E.M.; Collen, D.; Moons, L.; Carmeliet, P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci., 2005, 8, 85-92.
121. Carmeliet, P.; Storkebaum, E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders. Semin. Cell. Dev. Biol., 2002, 13, 39-53.
122. Lambrechts, D.; Storkebaum, E.; Morimoto, M.; Moreno- Murciano, M.P.; Appelmans, S.; Oh, H.; Van Damme, P.; Rutten, B.; Man, W.Y.; De Mol, M.; Wyns, S.; Manka, D.; Vermeulen, K.; Van Den Bosch, L.; Mertens, N.; Schmitz, C.; Robberecht, W.; Conway, E.M.; Collen, D.; Moons, L.; Carmeliet, P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat. Genet., 2003, 34, 383-94.
123. Del Bo, R.; Scarlato, M.; Martinelli-Boneschi, F. Haplotype analysis in VEGF gene and increate risk of Alzheimer's Disease. Ann. Neurol., 2005, 58, 488-9.
124. Chiappelli, M.; Borroni, B.; Archetti, S.; Calabrese, E.; Corsi, M.M.; Franceschi, M.; Padovani, A.; Licastro, F. VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment. Rejuvenation Res., 2006, 9, 485-93.
125. Borroni, B.; Ghezzi, S.; Agosti, C.; Archetti, S.; Fenoglio, C.; Galimberti, D.; Scarpini, E.; Di Luca, M.; Bresolin, N.; Comi, G.P.; Padovani, A.; Del Bo, R. Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. Rejuvenation Res., 2008, 11, 773-80.
126. Borroni, B.; Del Bo, R.; Goldwurm, S.; Archetti, S.; Bonvicini, C.; Agosti, C.; Bigni, B.; Papetti, A.; Ghezzi, S.; Sacilotto, G.; Pezzoli, G.; Gennarelli, M.; Bresolin, N.; Comi, G.P.; Padovani, A. VEGF haplotypes are associated with increased risk to progressive supranuclear palsy and corticobasal syndrome. J. Alzheimers Dis., 2010, 21, 87-94.
127. Blum-Degen, D.; Heinemann, T.; Lan, J.; Pedersen, V.; Leblhuber, F.; Paulus, W.; Riederer, P.; Gerlach, M. Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Research, 1999, 834, 128-135.
128. Thorns, V.; Hansen, L.; Masliah, E. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease. Experimental Neurology, 1998, 15, 14-20.
129. Venturelli, E.; Villa, C.; Scarpini, E.; Fenoglio, C.; Guidi, I.; Lovati, C.; Marcone, A.; Cortini, F.; Scalabrini, D.; Clerici, F.; Bresolin, N.; Mariani, C.; Cappa, S.; Galimberti, D. Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration. Eur. J. Neurol., 2008, 15, 77-81.
130. Venturelli, E.; Villa, C.; Fenoglio, C.; Clerici, F.; Marcone, A.; Ghidoni, R.; Cortini, F.; Scalabrini, D.; Gallone, S.; Rainero, I.; Mandelli, A.; Restelli, I.; Binetti, G.; Cappa, S.; Mariani, C.; Giordana, M.T.; Bresolin, N.; Scarpini, E.; Galimberti, D. The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur. J. Neurol., 2009, 16, 37-42.
131. Golser, R.; Gorren, A.C.F.; Mayer, B.; Schmidt, K. Functional characterization of Glu298Asp mutant human endothelial nitric oxide synthase purified from a yeast expression system. Nitric. Oxide., 2003, 8, 7-14.
132. Galimberti, D.; Venturelli, E.; Villa, C.; Fenoglio, C.; Clerici, F.; Marcone, A.; Benussi, L.; Cortini, F.; Scalabrini, D.; Perini, L.; Restelli, I.; Binetti, G.; Cappa, S.; Mariani, C.; Bresolin, N.; Scarpini, E. MCP -1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. J. Alzheimers Dis., 2009, 17, 125-33.
133. Rovin, B.H.; Lu, L.; Saxena, R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem. Biophys. Res. Commun., 1999, 259, 344-8.
134. Gonzalez, E.; Rovin, B.H.; Sen, L.; Cooke, G.; Dhanda, R.; Mummidi, S.; Kulkarni, H.; Bamshad, M.J.; Telles, V.; Anderson, S.A.; Walter, E.A.; Stephan, K.T.; Deucher, M.; Mangano, A.; Bologna, R.; Ahuja, S.S.; Dolan, M.J.; Ahuja, S.K. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 795-800.
135. Fisher, S.E.; Scharff, C. FOXP2 as a molecular window into speech and language. Trends Genet., 2009, 25, 166-77.
136. Lai, C.S.; Fisher, S.E.; Hurst, J.A.; Vargha-Khadem, F.; Monaco, A.P. A forkheaddomain gene is mutated in a severe speech and language disorder. Nature, 2001, 413, 519-523.
137. Tolosa, A.; Sanjuán, J.; Dagnall, A.M.; Moltó, M.D.; Herrero, N.; de Frutos, R. FOXP2 gene and language impairment in schizophrenia: association and epigenetic studies. BMC. Med. Genet., 2010, 22, 114
138. [Padovani, A.; Cosseddu, M.; Premi, E.; Archetti, S.; Papetti, A.; Agosti, C.; Bigni, B.; Cerini, C.; Paghera, B.; Belelli, G.; Borroni, B. The speech and language FOXP2 gene modulates thephenotye of frontotemporallobar de generation: a neuropsyholgical and neuroimaging study. In press.
139. Fenoglio, C.; Galimberti, D.; Piccio, L.; Scalabrini, D.; Panina, P.; Buonsanti, C.; Venturelli, E.; Lovati, C.; Forloni, G.; Mariani, C.; Bresolin, N.; Scarpini, E. Absence of TREM2 polymorphisms in patients with Alzheimer's disease and Frontotemporal Lobar Degeneration. Neurosci. Lett., 2007, 411, 133-7.
140. Reif, A.; Scarpini, E.; Venturelli, E.; Töpner, T.; Fenoglio, C.; Lesch, K.P.; Galimberti, D. The functional MAOA-uVNTR pro moter polymorphism in patients with frontotemporal dementia. Eur. J. Neurol., 2008, 15, 637-9.
141. Russ, C.; Lovestone, S.; Bakerc, M.; Pickering-Brown, S.M.; Andersen, P.M.; Rob, Furlong, R.; Manng, D.; Powella, J.F. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. Neuroscience. Letters., 2001, 299, 156-158.
142. Ingelson, M.; Fabre, S.F.; Lilius, L. Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. Neuroreport., 2001, 12, 905-909.
143. Morris, H.R.; Baker, M.; Yasojima, K.; Houlden, H.; Khan, M.N.; Wood, N.W.; Hardy, J.; Grossman, M.; Trojanowski, J.; Revesz, T.; Bigio, H.; Bergeron, C.; Janssen, J.C.; McGeer, P.L.; Rossor, M.N.; Lees, A.J.; Lantos, P.L.; Hutton, M. Analysis of tau haplotypes in Pick's disease. Neurology, 2002, 59, 443-5.
144. Short, R.A.; Graff-Radford, N.R.; Adamson, J.; Baker, M.; Hutton, M. Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch. Neurol., 2002, 59, 611-615.
145. Panegyres, P.K.; Zafiris-Toufexis, K. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders. Eur. J. Neurol., 2002, 9, 485-489.
146. Sobrido, M.J.; Abu-Khalil, A.; Weintraub, S.; Johnson, N.; Quinn, B.; Cummings, J.L.; Mesulam, M.M.; Geschwind, D.H. Possible association of the tau H1/H1 genotype with primary progressive aphasia. Neurology, 2003, 60, 862-4.
147. Johansson, A.; Zetterberg, H.; Håkansson, A.; Nissbrandt, H.; Blennow, K. TAU haplotype and the Satohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease. Neuro-degenerative diseases, 2005, 2, 28-35.
148. Mehta, S.G.; Watts, G.D.; Adamson, J.L.; Hutton, M.; Umberger, G.; Xiong, S.; Ramdeen, S.; Lovell, M.A.; Kimonis, V.E.; Smith, C.D. APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genet. Med., 2007, 9, 9-13.
149. Pickering-Brown, S.M.; Owen, F.; Isaacs, A.; Snowden, J.; Varma, A.; Neary, D.; Furlong, R.; Daniel, S.E.; Cairns, N.J.; Mann, D.M. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with pickor microvacuolar-type histology. Exp. Neurol., 2000, 163, 452-6.
150. Riemenschneider, M.; Diehl, J.; Müller, U.; Förstl, H.; Kurz, A. Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J. Neurol. Neurosurg. Psychiatry., 2002, 72, 639-41.
151. Nielsen, A.S.; Ravid, R.; Kamphorst, W.; Jørgensen, O.S. Apolipoprotein E epsilon 4 in an autopsy series of various dementing disorders. J. Alzheimers Dis., 2003, 5, 119-25.
152. Mann, D.M.; McDonagh, A.M.; Snowden, J.; Neary, D.; Pickering- Brown, S.M. Molecular classification of the dementias. Lancet, 2000, 355, 626.
153. Nicosia, F.; Alberici, A.; Benussi, L.; Gasparini, L.; Ghidoni, R.; Mazzoli, F.; Zanetti, O.; Frisoni, G.B.; Geroldi, C.; Binetti, G. Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer's disease. Dement. Geriatr. Cogn. Disord., 2001, 12, 305-8.
154. Fehér, A.; Juhász, A.; Rimanóczy, A.; Kálmán, J.; Janka, Z. Association between BDNF Val66Met polymorphism and Alzheimer disease, dementia with Lewy bodies, and Pick disease. Alzheimer Dis. Assoc. Disord., 2009, 23, 224-8.
155. Johansson, A.; Hampel, H.; Faltraco, F.; Buerger, K.; Minthon, L.; Bogdanovic, N.; Sjögren, M.; Zetterberg, H.; Forsell, L.; Lilius, L.; Wahlund, L.O.; Rymo, L.; Prince, J.A.; Blennow, K. Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci. Lett., 2003, 340, 69-73.
156. Vilariño-Güell, C.; Wider, C.; Soto-Ortolaza, A.I.; Cobb, S.A.; Kachergus, J.M.; Keeling, B.H.; Dachsel, J.C.; Hulihan, M.M.; Dickson, D.W.; Wszolek, Z.K.; Uitti, R.J.; Graff-Radford, N.R.; Boeve, B.F., Josephs, K.A., Miller, B., Boylan, K.B., Gwinn, K., Adler, C.H., Aasly, J.O., Hentati, F., Destée, A., Krygowska-Wajs, A., Chartier-Harlin, M.C., Ross, O.A., Rademakers, R., Farrer, M.J. Characterization of DCTN1 genetic variability in neurodegeneration. Neurology, 2009, 72, 2024-8.
157. Schaffer, B.A.; Bertram, L.; Miller, B.L.; Mullin, K.; Weintraub, S.; Johnson, N.; Bigio, E.H.; Mesulam, M.; Wiedau-Pazos, M.; Jackson, G.R.; Cummings, J.L.; Cantor, R.M.; Levey, A.I.; Tanzi, R.E.; Geschwind, D.H. Association of GSK3B with Alzheimer disease and frontotemporal dementia. Arch. Neurol., 2008, 65, 1368-7.
158. Hernandez, D.; Paisan Ruiz, C.; Crawley, A.; Malkani, R.; Werner, J.; gwinn-Hardy, K.; Dickson, D.; Wavrant Devrieze, F.; Hardy, J.; Singleton, A. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases. Neuroscie. Let., 2005, 389, 137-9.